I hope you're right concerning of low volume. (Today it jumped up 60k and achieve $.37, but it isn't a big change!)
LADR won't be our business, it'll milk SK after CB selling off, IMO. ALDOX got more importancy in ImmunityBio prestation, so PSS might get back from the self. His 'new' company's value is higher owning a phase3 Aldox. I hope he will own it buying out CytRx, than just a license user!
My card must show the future, we'll be rich if we hold shares til the end!
Waiting hard!
GLTY